Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
The Community Outreach Specialist (COS) program aimed to increase COVID-19 vaccine uptake among rural communities through targeted outreach efforts. The program trained and deployed community outreach specialists who engaged with community members, provided education about COVID-19 and vaccination, addressed concerns and misconceptions, and facilitated access to vaccination services. The COS program in reaching and engaging with socially vulnerable and medically underserved populations, successfully increasing vaccine acceptance and uptake in these communities by building trust, addressing barriers to vaccination, and tailoring outreach strategies to the local context. The article discusses the importance of community-based approaches, cultural competency, and collaboration with local organizations and leaders in achieving successful vaccine outreach. It also emphasizes the need for sustained efforts to ensure equitable access to vaccination and to address disparities in vaccine uptake among different populations.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
COVID-19 caused significant disruptions to routine vaccination efforts worldwide. Several factors contributed to these disruptions, including reduced healthcare access, fear of infection, and diversion of healthcare resources towards COVID-19 response. These led to a decline in immunization rates, leaving populations vulnerable to vaccine-preventable diseases. The article emphasizes the importance of addressing these collateral impacts and implementing strategies to mitigate the negative consequences. It suggests various approaches such as ensuring vaccine supply chains, enhancing public trust in vaccines, and implementing catch-up vaccination campaigns. The authors stress the need for collaborative efforts between public health agencies, healthcare providers, and communities to restore and maintain routine immunization services amidst the ongoing pandemic.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This analysis identifies risk factors and socio-economic impacts of long COVID with a public health lens. It notes that more analysis is needed, but encourages the impacts of long COVID to be seen within a larger social, and not just medical, context. Workplace and family structure implications are substantial. Long COVID should be tracked as distinct condition using person-centered research techniques that include traditionally underrepresented populations such as children.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
White Paper/Brief
This article discusses the development of the Visible app, which uses wearables or smart watches to help measure and manage long COVID. Visible helps to manage long COVID and other chronic fatigue diseases with a heartrate-monitored guidance strategy that emphasizes pacing as long COVID patients return to physical activity.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This study compares data from the NYC coronavirus data repository with 2018 American Community Survey 5-year census estimates to examine the distribution of testing sites across New York City by race in May 2020. During this time, the results found that testing sites for primarily Black and Latinx communities increased, but primarily White areas still had the highest number of testing sites. The study team created ZIP-code level maps showing testing site distribution using ArcGIS as a part of this study.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This article conducts a retrospective case-control study of electronic health records of individuals who were diagnosed with COVID-19 and have a recent diagnosis of substance use disorder (SUD). The results show that those diagnosed with SUD, particularly African Americans and those with opioid use disorder (OUD), are more likely to contract COVID-19, as well as suffer worsening outcomes such as hospitalization and mortality due to COVID-19. This article shows that an increase in SUD screening could be a factor in mitigating the spread of COVID-19 in this community.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article seeks to assess COVID-19 case and mortality rates in non-Hispanic American Indian and Alaska Natives (AI/AN) through an analysis of laboratory-reported COVID-19 data from January 22-July 3, 2020, for 23 U.S. states. The results show that AI/AN individuals are 3.5 times more likely to contract COVID-19 than White individuals, and more accurate race/ethnicity data must be reported by all states to more accurately represent this population.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This study examines a cohort of patients testing for COVID-19 in a large healthcare setting spanning California, Oregon, and Washington between March 1 and December 31, 2020. to determine the sociodemographic and clinical characteristics of these patients. Results found that major healthcare disparities were evident, particularly among Hispanics. Hispanic individuals tested positive at a higher rate, required excess hospitalization and mechanical ventilation, and had higher odds of in-hospital mortality despite younger ages. Targeted, culturally responsive interventions and equitable vaccine development and distribution are needed to address the increased risk of poorer COVID-19 outcomes among minority populations.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This article summarizes the findings from a systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnancy and lactation. In total, 23 studies were identified. The systematic review found that COVID-19 vaccines are safe, immunogenic, and effective during pregnancy and lactation.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This article discusses the findings from a systematic review and meta-analysis of observational studies on pregnant women with confirmed COVID-19 infections. More than 31,000 pregnant women from 62 studies were included.